The small, but vibrant, remaining Greek community in Cairo, Egypt has its roots deep in history. These are no mean achievements for the Greeks of Cairo, who since the mid-1950s have abandoned Egypt in ...

Cairo, Egypt – AVEVA, a global leader in industrial software, driving digital transformation and sustainability, has announced its new office in Cairo, Egypt. This expansion is set to strengthen ...

This neighborhood in southern Cairo is the oldest part of the city, with twisting alleyways and ancient churches that are several centuries older than the ornate mosques of Islamic Cairo.

The 24-month metastasis-free survival rate was 75.1% in the durvalumab arm and 65.1% in the control arm. Perioperative durvalumab improves upon neoadjuvant chemotherapy in patients with cisplatin ...

The median progression-free survival was 6.5 months, and the median overall survival was 18.3 months. The combination of savolitinib and durvalumab demonstrated activity in a phase 2 trial of ...

Copyright 2025 The Associated Press. All Rights Reserved. Egyptian Foreign Minister Badr Abdelatty, right, meets with Jordan’s Foreign Minister Ayman Safadi at ...

Perioperative durvalumab with neoadjuvant chemotherapy significantly improves EFS, OS, and metastasis-free survival in muscle-invasive bladder cancer. The durvalumab arm showed a 10% increase in ...

Expanded access program of cretostimogene grenadenorepvec in patients with non-muscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin. This is an ASCO Meeting Abstract from the 2025 ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

The table above is the complete Cairo Ramadan Calendar 2025. Here you can see the Sehri timing and iftar timing in Cairo from the first to the last Ramadan fasting day. The Islamic and Gregorian ...

It potentially predicts response to treatment. If we look at the patients who responded to therapy with the savolitinib and durvalumab combination, 22% of the responders were ctDNA positive at ...